BPC-157 Dosage Guide: Protocol, Timing, and What to Expect

BPC-157 (Body Protection Compound-157) is one of the most widely used peptides in the research and wellness community. Originally derived from a protein found in human gastric juice, it's gained a reputation for its potential healing and recovery properties — particularly for tendons, ligaments, muscles, and the gut.

But figuring out how to dose it, when to take it, and what to realistically expect is where most people get stuck. This guide covers the practical details: dosing ranges, injection vs. oral, cycling, stacking with TB-500, and a week-by-week timeline of what users typically report.

Note: This is educational content based on community experience and published research. BPC-157 is sold as a research peptide. Always consult a healthcare provider before starting any new protocol.

Standard BPC-157 Dosing Ranges

There's no FDA-approved dosing for BPC-157 since it's a research peptide, but the community has settled on well-established ranges based on animal research data scaled to human body weight and years of anecdotal experience.

Body weight consideration: Heavier individuals (200+ lbs) often trend toward the higher end of these ranges. Lighter individuals may see results at the lower end. The research-derived dose is approximately 1–10mcg per kg of body weight per day.

Subcutaneous Injection vs. Oral BPC-157

BPC-157 is somewhat unique among peptides because it shows activity through both injection and oral routes. Here's how they compare:

Subcutaneous (SubQ) Injection

• •Most common method. The majority of BPC-157 users inject subcutaneously, typically in the abdominal fat or as close to the injury site as practical.
• •Higher bioavailability. Injected BPC-157 enters the bloodstream more directly and consistently than oral.
• •Local vs. systemic. Injecting near an injury site provides both local and systemic effects. The "inject close to the injury" approach is popular in the community, though systemic effects occur regardless of injection site.
• •Requires reconstitution. You'll need BAC water, syringes, and alcohol swabs. See our reconstitution guide for the full process.

Oral BPC-157

• •Viable for gut-related issues. BPC-157 was originally isolated from gastric juice, and oral administration shows particular promise for gut healing — IBS, leaky gut, gastric ulcers, and NSAID-related GI damage.
• •Available as capsules or liquid. Some vendors sell oral BPC-157 in capsule form or as a stable oral solution. No needles required.
• •Higher doses often used. Oral bioavailability is lower, so oral protocols typically use 500mcg–1mg per day. Some use even higher doses for GI-specific goals.
• •Less proven for musculoskeletal injuries. For tendon, ligament, or muscle healing, SubQ injection is generally preferred. Oral may still provide systemic benefit, but the evidence is stronger for injection.

The practical answer: If you're addressing a specific injury (knee tendon, shoulder, elbow), inject SubQ. If you're primarily targeting gut health, oral is a reasonable option. Many users do both — injecting for systemic/injury healing and taking oral for gut support.

Timing and Frequency

• •Once daily is the most common protocol. Most users dose in the morning on an empty stomach.
• •Twice daily (split dose) is used at higher total daily doses. For example, 250mcg morning + 250mcg evening instead of 500mcg once. Some believe splitting maintains more stable levels throughout the day.
• •Empty stomach preferred. Most community protocols recommend dosing at least 30 minutes before eating, though this isn't strictly necessary for SubQ injection.
• •Consistency matters more than timing. Picking a time and sticking to it daily is more important than optimizing the exact hour. Set a reminder or log it with a tracker to stay consistent.

Cycling BPC-157

Unlike hormonal compounds, BPC-157 doesn't appear to cause tolerance or require post-cycle therapy. However, most users still run it in cycles:

• •Standard cycle: 4–6 weeks. This is the most common duration. Most users report noticeable results within this window and stop once their healing goal is met.
• •Extended cycle: 8–12 weeks. Used for more significant injuries or chronic conditions. Take a 2–4 week break before starting another cycle.
• •As-needed use. Some people use BPC-157 situationally — after a new injury, during intense training blocks, or when gut issues flare up — rather than on a fixed schedule.

When to stop: If you've achieved your healing goal, stop. There's no need to continue indefinitely. If you're not seeing any results after 4 weeks, reassess your dosage, source quality, and whether BPC-157 is the right compound for your situation.

Stacking BPC-157 with TB-500

The BPC-157 + TB-500 combination is one of the most popular peptide stacks in the community, often called the "healing stack." Here's why they're paired together and how people typically run it.

Why They Work Together

BPC-157 and TB-500 (Thymosin Beta-4) work through different but complementary mechanisms. BPC-157 is thought to promote angiogenesis (new blood vessel formation) and modulate growth factors locally. TB-500 promotes cell migration, reduces inflammation, and supports tissue repair more broadly. Together, they address healing from multiple angles.

Typical Healing Stack Protocol

Want a ready-made protocol? Check out our Healing Stack template — it includes both compounds pre-configured with dosages you can import directly into your tracker.

What to Expect: Week-by-Week Timeline

Results vary significantly depending on the injury, dose, individual response, and source quality. That said, here's what users commonly report:

Side Effects and Safety

BPC-157 has a strong safety profile in the available research. In animal studies, no toxic dose has been established — meaning researchers couldn't find a dose high enough to cause toxicity. That said, it's still a research compound without completed human clinical trials.

Commonly reported side effects (generally mild):

• •Mild nausea (more common with oral dosing)
• •Dizziness or lightheadedness (usually transient)
• •Injection site redness or irritation
• •Headache (uncommon)
• •Changes in appetite

For a more detailed safety overview, see the BPC-157 page in our peptide library.

Track Your BPC-157 Protocol

Running a BPC-157 cycle is one thing. Remembering exactly what you took, when, and how you felt three weeks in? That's where tracking comes in. A consistent log helps you evaluate whether the protocol is working and provides useful data if you need to adjust your approach.

Peptide Assistant is a free tracker built specifically for this. Add BPC-157 (and TB-500 if you're stacking), log your daily dose in seconds, and review your calendar to see your consistency at a glance. No subscription, no download, works on any device.